Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2005 1
2006 1
2008 1
2010 1
2011 1
2012 1
2013 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Repression of cancer cell senescence by PKCι.
Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard MA, Parolin DA, Lavictoire SJ, Amin MS, Islam S, Lorimer IA. Paget JA, et al. Among authors: parolin da. Oncogene. 2012 Aug 2;31(31):3584-96. doi: 10.1038/onc.2011.524. Epub 2011 Nov 28. Oncogene. 2012. PMID: 22120720
Coordination of glioblastoma cell motility by PKCι.
Baldwin RM, Barrett GM, Parolin DA, Gillies JK, Paget JA, Lavictoire SJ, Gray DA, Lorimer IA. Baldwin RM, et al. Among authors: parolin da. Mol Cancer. 2010 Sep 3;9:233. doi: 10.1186/1476-4598-9-233. Mol Cancer. 2010. PMID: 20815904 Free PMC article.
PKCι depletion initiates mitotic slippage-induced senescence in glioblastoma.
Restall IJ, Parolin DA, Daneshmand M, Hanson JE, Simard MA, Fitzpatrick ME, Kumar R, Lavictoire SJ, Lorimer IA. Restall IJ, et al. Among authors: parolin da. Cell Cycle. 2015;14(18):2938-48. doi: 10.1080/15384101.2015.1071744. Cell Cycle. 2015. PMID: 26208522 Free PMC article.
Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells.
Gunaratnam L, Morley M, Franovic A, de Paulsen N, Mekhail K, Parolin DA, Nakamura E, Lorimer IA, Lee S. Gunaratnam L, et al. Among authors: parolin da. J Biol Chem. 2003 Nov 7;278(45):44966-74. doi: 10.1074/jbc.M305502200. Epub 2003 Aug 27. J Biol Chem. 2003. PMID: 12944410 Free article.
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
Goss G, Hirte H, Miller WH Jr, Lorimer IA, Stewart D, Batist G, Parolin DA, Hanna P, Stafford S, Friedmann J, Walsh W, Mathews S, Douglas L, Seymour LK. Goss G, et al. Among authors: parolin da. Invest New Drugs. 2005 Mar;23(2):147-55. doi: 10.1007/s10637-005-5860-y. Invest New Drugs. 2005. PMID: 15744591 Clinical Trial.
11 results